A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234
Status:
NOT_YET_RECRUITING
Trial end date:
2026-03-24
Target enrollment:
Participant gender:
Summary
This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of AZD6234.
This study will take place at one site in Nottingham, United Kingdom, and will enrol 21 healthy men and women aged 18-55 years.